Wellcome Trust’s Accenture ACN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $329M | Hold |
1,100,000
| – | – | 3.79% | 13 |
|
|
2025
Q1 | $343M | Hold |
1,100,000
| – | – | 4.29% | 11 |
|
|
2024
Q4 | $387M | Hold |
1,100,000
| – | – | 4.67% | 9 |
|
|
2024
Q3 | $389M | Hold |
1,100,000
| – | – | 4.73% | 9 |
|
|
2024
Q2 | $334M | Hold |
1,100,000
| – | – | 4.27% | 10 |
|
|
2024
Q1 | $381M | Hold |
1,100,000
| – | – | 4.58% | 9 |
|
|
2023
Q4 | $386M | Hold |
1,100,000
| – | – | 4.78% | 9 |
|
|
2023
Q3 | $338M | Hold |
1,100,000
| – | – | 4.49% | 10 |
|
|
2023
Q2 | $339M | Hold |
1,100,000
| – | – | 4.47% | 11 |
|
|
2023
Q1 | $314M | Hold |
1,100,000
| – | – | 4.39% | 11 |
|
|
2022
Q4 | $294M | Hold |
1,100,000
| – | – | 4.34% | 11 |
|
|
2022
Q3 | $283M | Hold |
1,100,000
| – | – | 4.44% | 9 |
|
|
2022
Q2 | $305M | Hold |
1,100,000
| – | – | 3.98% | 14 |
|
|
2022
Q1 | $371M | Hold |
1,100,000
| – | – | 3.88% | 11 |
|
|
2021
Q4 | $456M | Hold |
1,100,000
| – | – | 4.33% | 8 |
|
|
2021
Q3 | $352M | Hold |
1,100,000
| – | – | 3.48% | 17 |
|
|
2021
Q2 | $324M | Hold |
1,100,000
| – | – | 3.09% | 18 |
|
|
2021
Q1 | $304M | Hold |
1,100,000
| – | – | 3.17% | 16 |
|
|
2020
Q4 | $287M | Hold |
1,100,000
| – | – | 2.94% | 15 |
|
|
2020
Q3 | $249M | Hold |
1,100,000
| – | – | 3.36% | 16 |
|
|
2020
Q2 | $236M | Buy |
1,100,000
+830,000
| +307% | +$178M | 3.59% | 15 |
|
|
2020
Q1 | $44.1M | Buy |
+270,000
| New | +$44.1M | 0.79% | 19 |
|